Menveo

meningococcal group A, C, W-135 and Y conjugate vaccine · GSK Vaccines S.r.l.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Menveo, covering 2010-08-04 to 2026-07-10. Get the full timeline:

Most recent: EMA Authorised: Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine) — GSK Vaccines S.r.l.